Transthoracic Coronary Sinus Blood Flow Monitoring and PC6 Transcutaneous Electrical Acupoint Stimulation in Elderly Hip Fracture Surgery: A Three-phase Randomised Trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background Perioperative myocardial injury in elderly hip fracture patients is usually silent and arises mainly from oxygen supply–demand mismatch. Transthoracic echocardiographic coronary sinus blood flow (CSBF) has been proposed as a non-invasive window on coronary perfusion, but its obtainability in this frail population is unknown. This trial assessed whether a definitive trial of PC6 transcutaneous electrical acupoint stimulation (TEAS) using such monitoring is feasible. Methods Three-phase, single-centre, sham-controlled randomised pilot and feasibility trial (June 2023–May 2025). Phase I (n = 30) assessed CSBF obtainability and acute responses to bilateral PC6 TEAS; Phase II (n = 60) explored stimulation parameters in a 2 × 2 factorial (2 vs. 5 Hz; 15 vs. 25 min); Phase III (n = 40) applied the leading combination under standardised total intravenous anaesthesia. Primary outcomes were feasibility outcomes: CSBF obtainability, predictors of measurement failure, recruitment, retention and safety. Clinical measures were secondary and exploratory, and progression criteria were pre-specified. The study was not powered to detect efficacy effects. Results Adequate CSBF spectra were obtainable in 64% of patients (55/85, Phases I–II). Chronic obstructive pulmonary disease (adjusted odds ratio 3.45), body mass index above 25 kg/m 2 (2.87) and thoracic kyphosis (3.21) independently predicted failure; obtainability reached 90.5% when none was present but fell to 56.8% intraoperatively. Recruitment averaged 4.4 patients/month, no patient was lost to follow-up, and no adverse event was attributable to TEAS. Exploratory estimates: coronary sinus velocity–time integral rose 20.8% (95% CI 11.2–30.4) without change in mean arterial pressure; rate-pressure product remained below 12,000 throughout in the TEAS arm, with a pooled between-group separation of 1759 (95% CI 876–2642) at peak-stress time points. Discussion A definitive trial is feasible, but not with transthoracic CSBF as its monitoring backbone: the technique fails in approximately a third of patients, and selectively in those at highest cardiovascular risk. We recommend proceeding with an amended protocol that substitutes pulse-wave analysis. The haemodynamic signals reported here are hypothesis-generating. Trial registration Chinese Clinical Trial Registry (https://www.chictr.org.cn), ChiCTR2600126845; registered 17 June 2026, retrospectively registered. Recruitment ran from June 2023 to May 2025, so registration followed completion of recruitment.
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: coronary sinus blood flow, transthoracic echocardiography, transcutaneous electrical acupoint stimulation, perioperative myocardial injury, coronary perfusion, frailty, chronic obstructive pulmonary disease, thoracic kyphosis, body mass index, feasibility, total intravenous anesthesia, rate-pressure product
Open Access status: hybrid
OpenAlex ID: W7225876988
